我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

炎症标记物与冠心病关系的研究进展(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2008年第3期
页码:
359-362
栏目:
综述
出版日期:
2008-05-20

文章信息/Info

Title:
-
作者:
李巧汶 综述 邱健 审校
广州军区广州总医院心血管内科, 广东 广州 510010
Author(s):
-
关键词:
冠状动脉疾病炎症标志物C反应蛋白炎症细胞因子黏附分子
Keywords:
-
分类号:
R541.5
DOI:
-
文献标识码:
A
摘要:
随着对冠心病(CHD)发病机制研究的深入,炎症学说倍受重视,多种炎症标志物与CHD的关系成为CHD研究领域的一个热点,它们在CHD的诊断、危险分层、治疗及预后预测中有一定的临床意义,作者就此方面的研究进展作一综述。
Abstract:
-

参考文献/References

[1] 臧益民,樊荣. 加强多学科协作,争取心血管病研究取得进展[J]. 心脏杂志, 2006, 18(5):483-488.

[2] Chalikias GK, Tziakas DN, Kaski JC, et al.Interleukin18: interleukin10 ratio and inhospital adverse events in patients with acute coronary syndrome[J]. Atherosclerosis, 2005, 182 (1):135-143.

[3] Koenig W, Khuseyinova N, Baumert J, et al. Increased concentrations of Creactive protein and IL6 but not IL18 are independently associated with incident coronary events in middleaged men and women: results from the MONICA/KORA Augsburg casecohort study, 19842002[J]. Arterioscler Thromb Vasc Biol, 2006, 26(12):2745-2751.

[4] Dubey L, Hesong Z. Antiinflammatory action of diltiazem in patients with unstable angina[J]. Postgrad Med J, 2006, 82(971):594-597.

[5] Mazighi M, Pelle A, Gonzalez W, et al. IL10 inhibits vascular smooth muscle cell activation in vitro and in vivo[J]. Am J Physiol Heart Circ Physiol, 2004, 287(2):H866-H871.

[6] Monraats PS, Kurreeman FA, Pons D, et al. Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention[J]. Genes Immun, 2007, 8(1):44-50.

[7] Heinisch RH, Zanetti CR, Comin F, et al. Serial changes in plasma levels of cytokines in patients with coronary artery disease[J]. Vasc Health Risk Manag, 2005, 1(3):245-250.

[8]Mysliwska J, Wieckiewicz J, Hak L, et al. Interleukin 6 polymorphism corresponds to the number of severely stenosed coronary arteries[J]. Eur Cytokine Netw, 2006, 17(3):181-188.

[9] Stefan KJ, Paul A, Elliott B, et al. Tropoein and Creactive protein have different relational to subsequent mortality and myocardial infarction after acute coronary syndrome[J]. J Am Coll Cardiol, 2003, 41(5):916-924.

[10]Saleh N, Tornvall P. Serum Creactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis[J]. Atherosclerosis, 2006, 70 (6):538-540.

[11]Kozinski M, Kubica J, Sukiennik A, et al. Periprocedural soluble P and Eselectin levels fail as predictors of clinical restenosis in patients treated with elective coronary stenting[J]. Circulation, 2007, 19(1):187-195.

[12]Sattar N, Murray HM, McConnachie A, et al. CReactive protein and prediction of coronary heart disease and global vascular events in the prospective study of pravastatin in the elderly at risk (PROSPER)[J]. Circulation, 2007, 115(8):981-989.

[13]Guray U, Erbay AR, Guray Y, et al. Levels of solube adhesion molecules in various clinical presentations of coronary atherosclerosis[J]. Int J Cardiol, 2004, 96(2):235-240.

[14]Kollum M, Hoefer I, Schreiber R, et al. Systemic application of antiICAM1 monoclonal antibodies to prevent restenosis in rabbits: an antiinflammatory strategy[J].Coron Artery Dis, 2007, 18 (2):117-123.

[15]Merten M, Thiagarajan P. Pselectin in arterial thrombosis[J]. Z Kardiol, 2004, 93(11):855-863.

[16]Venturinelli ML, Hovnan A, Soeiro Ade M, et al. Platelet activation in different clinical forms of the coronary artery disease (roll of Pselectin and others platelet markers in the stable and unstable angina)[J]. Arq Bras Cardiol, 2006, 87(4):446-450.

[17]Inami N, Nomura S, Manabe K, et al. Plateletderived chemokine RANTES may be a sign of restenosis after percutaneous coronary intervention in patients with stable angina pectoris[J]. Platelets, 2006, 17(8):565-570.

[18]林国强,蒋海河,李迎秋. CHD患者血浆血管性血友病因子、可溶性E选择素的变化及意义[J]. 中南大学学报, 2005, 30(4):399-402.

[19]AbuAmero KK, AlBoudari OM, Mohamed GH, et al. Eselectin S128R polymorphism and severe coronary artery disease in Arabs[J]. BMC Med Genet, 2006, 7:52.

[20]Miller MA, Kerry SM, Dong Y, et al. Circulating soluble Eselectin levels and the Ser 128Arg polymorphism in individuals from different ethnic groups[J]. Nutr Metab Cardiovasc Dis, 2005, 15 (1):65-70.

[21]Kilickap M, Tutar E, Aydintug O, et al. Increase in soluble Eselectin level after PTCA and stent implantation: a potential marker of restenosis[J]. Int J Cardiol, 2004, 93(1):13-18.

[22]Seino Y, Ogawa A, Yamashita T, et al. Multibiomarker approach to acute coronary syndrome[J]. Nippon Rinsho, 2006, 64(4):691-699.

备注/Memo

备注/Memo:
收稿日期:2007-04-05.通讯作者:邱健,教授,主要从事冠心病和心力衰竭方面研究 Email:guxiaolong3310@163.com 作者简介:李巧汶,医师,硕士Email:stevenxtf@sina.com
更新日期/Last Update: